Injection of Ranibizumab Versus Combination of Ranibizumab and Triamcinolone Acetate for (CRVO)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE4
Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy
- Status
- WITHDRAWN
- Phase
- PHASE4
Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion
- Status
- UNKNOWN
- Phase
- PHASE4
Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery
- Status
- UNKNOWN
- Phase
- NA
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
- Status
- COMPLETED
- Phase
- PHASE4
Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD
- Status
- COMPLETED
- Phase
- PHASE2
To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)
- Status
- UNKNOWN
- Phase
- PHASE3
Ziv-aflibercept Efficacy in Better Regulating AMD
- Status
- COMPLETED
- Phase
- PHASE2
Time Course of Activity Signs at SD-OCT High Frequency Intravitreal Ranibizumab Treatment in CNV Due to AMD
- Status
- COMPLETED
- Phase
- PHASE4
A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD
- Status
- COMPLETED
- Phase
- PHASE2
Refractive Error and Biometry in Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- N/A
Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2